Company intelligence / Profile preview
Immugenia
Sherbrooke, Quebec, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Immugenia is a preclinical-stage immuno-oncology company developing hematopoietic stem cell-, T cell-, and NK cell–based CAR therapies using proprietary synthetic promoters enabling selective CAR expression in T and NK cells, initially targeting pediatric and other liquid and solid tumors; no human clinical data have been reported yet.[1][3][5]
- Therapeutic areas
- OncologyHematology
- Modalities
- CAR-T cell therapyNK cell therapyGene therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Participated in Johnson & Johnson Inaugural Gene Therapy Summit (relationship exploratory/BD-focused, not disclosed as a formal partnership)[1]Participated in CQDM/Brain Canada/Cole Foundation/Oncopole and Canadian Cancer Society pediatric brain and cancer research initiatives as part of funded collaborative ecosystems[1][4]
Beyond the preview
Go deeper on Immugenia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immugenia.